Aristotle Capital Management, LLC Amgen Inc Transaction History

Aristotle Capital Management, LLC

$50.8 Billion
Q1 2024

A detailed history of Aristotle Capital Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Aristotle Capital Management, LLC holds 4,043,775 shares of AMGN stock, worth $1.24 Billion. This represents 2.26% of its overall portfolio holdings.

Number of Shares

4,043,775

Previous 4,154,529 2.67%

Holding current value

$1.24 Billion

Previous $1.2 Billion 3.92%

% of portfolio

2.26%

Previous 2.48%

36 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$268.87 - $324.56 $29.8 Million - $35.9 Million	-110,754 Reduced 2.67%	4,043,775 $1.15 Billion
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $50.8 Million - $57.3 Million	-198,640 Reduced 4.56%	4,154,529 $1.2 Billion
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $31.5 Million - $39.1 Million	-143,898 Reduced 3.2%	4,353,169 $1.17 Billion
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $10.9 Million - $12.9 Million	-51,042 Reduced 1.12%	4,497,067 $998 Million
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $21.2 Million - $25.8 Million	-93,872 Reduced 2.02%	4,548,109 $1.1 Billion

Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $56.8 Million - $72.2 Million	-248,185 Reduced 5.08%	4,641,981 $1.22 Billion
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $16.2 Million - $18.3 Million	-72,128 Reduced 1.45%	4,890,166 $1.11 Billion
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $16.5 Million - $18.4 Million	-71,609 Reduced 1.42%	4,962,294 $1.21 Billion
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $4.9 Million - $5.42 Million	-22,352 Reduced 0.44%	5,033,903 $1.22 Billion
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $33.6 Million - $38.5 Million	169,143 Added 3.46%	5,056,255 $1.14 Billion
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $8.83 Million - $10.3 Million	41,586 Added 0.86%	4,887,112 $1.04 Billion
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $16.3 Million - $18.1 Million	69,858 Added 1.46%	4,845,526 $1.18 Billion
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $84.3 Million - $98.2 Million	379,885 Added 8.64%	4,775,668 $1.18 Billion
Q4 2020 Feb 22, 2021	BUY	$216.38 - $257.67 $131 Million - $157 Million	607,664 Added 16.04%	4,395,783 $1.01 Billion
Q4 2020 Feb 16, 2021	SELL	$216.38 - $257.67 $82.2 Million - $97.9 Million	-379,791 Reduced 9.11%	3,788,119 $867 Million
Q3 2020 Nov 16, 2020	BUY	$234.65 - $260.95 $13.9 Million - $15.5 Million	59,300 Added 1.44%	4,167,910 $1.06 Billion
Q2 2020 Aug 14, 2020	BUY	$197.81 - $242.74 $37.8 Million - $46.4 Million	190,968 Added 4.87%	4,108,610 $969 Million
Q1 2020 May 15, 2020	BUY	$182.24 - $241.7 $18.8 Million - $24.9 Million	102,970 Added 2.7%	3,917,642 $794 Million
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $240 Million - $309 Million	1,270,737 Added 49.95%	3,814,672 $920 Million
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $244,450 - $292,902	-1,404 Reduced 0.06%	2,543,935 $492 Million
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $6.23 Million - $7.3 Million	37,362 Added 1.49%	2,545,339 $469 Million
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $15.9 Million - $17.9 Million	87,846 Added 3.63%	2,507,977 $476 Million
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $8.83 Million - $10.3 Million	-49,498 Reduced 2.0%	2,420,131 $471 Million
Q3 2018 Sep 19, 2019	BUY	$185.29 - $208.89 $59.9 Million - $67.5 Million	323,194 Added 15.06%	2,469,629 $512 Million
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $49.1 Million - $55.4 Million	-265,020 Reduced 10.99%	2,146,435 $445 Million
Q2 2018 Sep 19, 2019	SELL	$166.05 - $186.51 $6.64 Million - $7.46 Million	-40,000 Reduced 1.63%	2,411,455 $445 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $28.6 Million - $32.1 Million	171,987 Added 7.55%	2,451,455 $453 Million
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $14.6 Million - $17.1 Million	86,378 Added 3.94%	2,279,468 $389 Million
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $114 Million - $128 Million	677,373 Added 44.69%	2,193,090 $381 Million
Q3 2017 Nov 14, 2017	SELL	$167.29 - $191.0 $847,825 - $967,988	-5,068 Reduced 0.33%	1,515,717 $283 Million
Q2 2017 Nov 16, 2017	BUY	N/A	79,443 Added 5.51%	1,520,785 $262 Million
Q1 2017 Nov 16, 2017	BUY	N/A	37,721 Added 2.69%	1,441,342 $236 Million
Q4 2016 Nov 16, 2017	BUY	N/A	59,766 Added 4.45%	1,403,621 $205 Million
Q3 2016 Nov 16, 2017	SELL	N/A	-27,896 Reduced 2.03%	1,343,855 $224 Million
Q2 2016 Nov 16, 2017	BUY	N/A	45,674 Added 3.44%	1,371,751 $209 Million
Q1 2016 Nov 17, 2017	BUY	N/A	1,326,077	1,326,077 $199 Million

Others Institutions Holding AMGN

# of Institutions

2,929

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $164B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aristotle Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aristotle Capital Management, LLC with notifications on news.

Account

Aristotle Capital Management, LLC Amgen Inc Transaction History